Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal cone cell | 7 studies | 39% ± 8% |
Insufficient scRNA-seq data for expression of PDE6C at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 95% | 47.74 | 2522 / 2642 | 19% | 0.27 | 136 / 705 |
kidney | 93% | 27.21 | 83 / 89 | 11% | 0.16 | 99 / 901 |
thymus | 100% | 48.84 | 652 / 653 | 4% | 0.06 | 26 / 605 |
esophagus | 97% | 34.70 | 1406 / 1445 | 6% | 0.08 | 11 / 183 |
lung | 99% | 40.03 | 571 / 578 | 4% | 0.08 | 51 / 1155 |
uterus | 99% | 65.96 | 169 / 170 | 4% | 0.06 | 17 / 459 |
breast | 99% | 42.56 | 454 / 459 | 4% | 0.08 | 46 / 1118 |
bladder | 100% | 50.57 | 21 / 21 | 3% | 0.06 | 14 / 504 |
ovary | 99% | 59.11 | 179 / 180 | 2% | 0.03 | 10 / 430 |
prostate | 100% | 55.05 | 245 / 245 | 1% | 0.01 | 4 / 502 |
intestine | 99% | 37.93 | 954 / 966 | 2% | 0.03 | 9 / 527 |
spleen | 100% | 46.68 | 241 / 241 | 0% | 0 | 0 / 0 |
skin | 97% | 40.26 | 1749 / 1809 | 1% | 0.01 | 5 / 472 |
stomach | 95% | 26.75 | 340 / 359 | 3% | 0.06 | 8 / 286 |
blood vessel | 97% | 34.01 | 1300 / 1335 | 0% | 0 | 0 / 0 |
adipose | 96% | 35.16 | 1157 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 93% | 24.09 | 241 / 258 | 1% | 0.01 | 2 / 230 |
liver | 89% | 23.53 | 202 / 226 | 5% | 0.09 | 19 / 406 |
muscle | 94% | 23.43 | 755 / 803 | 0% | 0 | 0 / 0 |
pancreas | 93% | 20.76 | 304 / 328 | 1% | 0.03 | 2 / 178 |
heart | 89% | 19.99 | 765 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 40% | 6.38 | 373 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.02 | 1 / 45 |
eye | 0% | 0 | 0 / 0 | 1% | 0.09 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007601 | Biological process | visual perception |
GO_0046549 | Biological process | retinal cone cell development |
GO_0019933 | Biological process | cAMP-mediated signaling |
GO_0007603 | Biological process | phototransduction, visible light |
GO_0005886 | Cellular component | plasma membrane |
GO_0047555 | Molecular function | 3',5'-cyclic-GMP phosphodiesterase activity |
GO_0004115 | Molecular function | 3',5'-cyclic-AMP phosphodiesterase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0030553 | Molecular function | cGMP binding |
Gene name | PDE6C |
Protein name | Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' (EC 3.1.4.35) (cGMP phosphodiesterase 6C) |
Synonyms | PDEA2 |
Description | FUNCTION: As cone-specific cGMP phosphodiesterase, it plays an essential role in light detection and cone phototransduction by rapidly decreasing intracellular levels of cGMP. . |
Accessions | ENST00000371447.4 P51160 |